All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
STRUCTURE THERAPEUTICS INC. Last Reported: 4/30/2024 Stock Symbol: GPCR

Business Address

611 GATEWAY BLVD SUITE 223

SOUTH SAN FRANCISCO , CA US 94080

Mailing Address

611 GATEWAY BLVD SUITE 223

SOUTH SAN FRANCISCO , CA US 94080
Phone Number: (628) 229-9277 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Cash and Cash Equivalents $97,832,000.00 $129,792,000.00 $50,636,000.00 $40,591,000.00 $126,493,000.00 $26,091,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $12,911,000.00 $6,285,000.00 $4,535,000.00 $3,635,000.00 $5,293,000.00 $2,248,000.00 -- -- -- --
Total Current Assets $449,360,000.00 $473,608,000.00 $209,959,000.00 $228,222,000.00 $246,155,000.00 $93,089,000.00 -- -- -- --
Property Plant and Equipement $3,120,000.00 $3,228,000.00 $2,408,000.00 $1,078,000.00 $961,000.00 $1,031,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- --
Other Assets $47,000.00 $45,000.00 $350,000.00 $38,000.00 $59,000.00 $3,463,000.00 -- -- -- --
Total Assets $457,225,000.00 $482,017,000.00 $216,370,000.00 $229,428,000.00 $247,353,000.00 $97,845,000.00 -- -- -- --
Accounts Payable $6,538,000.00 $4,742,000.00 $3,319,000.00 $5,699,000.00 $4,945,000.00 $6,009,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $27,407,000.00 $29,051,000.00 $23,406,000.00 $15,013,000.00 $11,002,000.00 $13,010,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-90,000.00 $521,000.00 $-310,000.00 $-390,000.00 $147,000.00 $-110,000.00 -- -- -- --
Accumulated Deficit $-232,608,000.00 $-206,572,000.00 $-182,069,000.00 $-158,200,000.00 $-134,900,000.00 $-116,952,000.00 -- -- -- --
Total Stockholders' Equity $429,818,000.00 $452,966,000.00 $192,964,000.00 $214,415,000.00 $236,351,000.00 $-115,140,000.00 $-103,913,000.00 $-92,103,000.00 $-77,231,000.00 $-64,735,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $457,225,000.00 $482,017,000.00 $216,370,000.00 $229,428,000.00 $247,353,000.00 $97,845,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Total Revenues -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- --
Research and Development $20,679,000.00 $70,103,000.00 $17,515,000.00 $19,411,000.00 $13,135,000.00 -- $9,160,000.00 $10,181,000.00 $8,492,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $32,015,000.00 $102,775,000.00 $26,145,000.00 $45,636,000.00 $19,649,000.00 -- $39,605,000.00 $13,960,000.00 $12,952,000.00 --
Loss from Operations $-32,015,000.00 $-102,775,000.00 $-71,781,000.00 $-25,987,000.00 $-19,649,000.00 -- $-12,693,000.00 $-26,912,000.00 $-12,952,000.00 --
Loss Before Income Taxes $-26,007,000.00 $-89,384,000.00 $-64,569,000.00 $-41,112,000.00 $-17,950,000.00 -- $-12,344,000.00 $-26,905,000.00 $-13,021,000.00 --
Earnings Per Share Basic $-0.19 $-0.81 $-0.21 $-0.44 $-0.25 -- $-1.27 $-1.64 $-1.44 --
Weighted Average Shares Basic 139,710,000 110,198,000 100,613,000 93,325,000 71,655,000 -- 9,428,000 9,435,000 9,063,000 --
Earnings Per Share Diluted $-0.19 $-0.81 $-0.65 $-0.20 $-0.25 -- $-1.27 $-3.09 $-1.44 --
Weighted Average Shares Diluted 139,710,000 110,198,000 100,613,000 93,325,000 71,655,000 -- 9,780,000 9,250,000 9,063,000 --
Common Stock Shares Authorized 500,000,000 500,000,000 -- -- 500,000,000 432,982,000 -- -- -- --
Common Stock Shares Outstanding 139,855,000 139,220,000 -- -- 114,730,000 10,527,000 -- -- -- --
Common Stock Value $14,000.00 $14,000.00 -- -- $11,000.00 $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 -- $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 90,188,000 90,188,000 100,000,000 92,589,482 100,000,000 -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com